Rifabutin
- Generic Name
- Rifabutin
- Brand Names
- Mycobutin, Talicia
- Drug Type
- Small Molecule
- Chemical Formula
- C46H62N4O11
- CAS Number
- 72559-06-9
- Unique Ingredient Identifier
- 1W306TDA6S
Overview
A broad-spectrum antibiotic that is being used as prophylaxis against disseminated Mycobacterium avium complex infection in HIV-positive patients.
Background
A broad-spectrum antibiotic that is being used as prophylaxis against disseminated Mycobacterium avium complex infection in HIV-positive patients.
Indication
For the prevention of disseminated Mycobacterium avium complex (MAC) disease in patients with advanced HIV infection.
Associated Conditions
- Helicobacter Pylori Infection
- Mycobacterium avium complex infection
- Tuberculosis (TB)
- Late phase Tuberculosis
Clinical Trials
FDA Approved Products
rifabutin
Manufacturer:Lupin Pharmaceuticals, Inc.
Route:ORAL
Strength:150 mg in 1 1
Approved: 2023/11/30
NDC:68180-285
Rifabutin
Manufacturer:Mylan Pharmaceuticals Inc.
Route:ORAL
Strength:150 mg in 1 1
Approved: 2023/02/24
NDC:59762-1350
Mycobutin
Manufacturer:REMEDYREPACK INC.
Route:ORAL
Strength:150 mg in 1 1
Approved: 2024/03/28
NDC:70518-3731
Talicia
Manufacturer:RedHill Biopharma Ltd
Route:ORAL
Strength:12.5 mg in 1 1
Approved: 2021/09/22
NDC:57841-1150
Mycobutin
Manufacturer:Department of State Health Services, Pharmacy Branch
Route:ORAL
Strength:150 mg in 1 1
Approved: 2016/03/11
NDC:55695-010
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath